We recently published a list of 15 Important AI News and Ratings on Investors’ Radar. In this article, we are going to take a ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, will provide an update to the investment community, ...

The Chicago health tech company's founder is "100% convinced" that in the coming years, it will be virtually impossible for a ...

has announced the development of a whole-genome sequencing test, named xH, aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the company ...

Bobbi Conner talks with MUSC's Dr. Kristen Lancaster about using rapid genetic testing for hospitalized children to determine ...

The company will be the first to integrate whole genome sequencing (WGS) into Epic's Aura platform, further advancing access ...

On January 13, the technology company announced the development of its first whole-genome sequencing test, xH, using artificial intelligence. This test aims to enhance precision medicine and ...

has announced the development of a whole-genome sequencing test, named xH, aimed at enhancing personalized treatment for hematological cancer patients. According to InvestingPro data, the company ...